Published in the Gastro Hep Advances journal, this new study revealed that while vitamin B1 can help reduce fatigue in patients with inflammatory bowel disease (IBD), its effectiveness depends on specific gut bacteria. Researchers found that the presence of a beneficial bacterium, Faecalibacterium prausnitzii (FP), is linked to a positive response. This bacterium is often found in people with healthy guts, and its absence or low levels in those with chronic illness may explain why some patients do not benefit from the vitamin.
The study, involving 40 IBD patients with chronic fatigue, provided each participant with vitamin B1 and a placebo during two periods of four weeks with a break in between. While the researchers initially sought a “fatigue microbiome,” they discovered that the gut bacteria of fatigued patients largely resembled those without fatigue. However, the presence of FP in higher numbers was strongly associated with reduced fatigue after treatment with vitamin B1.
Based on these results, lead author Professor Christian Lodberg Hvas now recommends high-dose vitamin B1 for patients with unexplained fatigue, particularly since the treatment has no side effects and is affordable.
To learn about research using vitamin D to treat IBD, as well as how Dr. Rath’s Cellular Medicine approach to digestive health can help, see this article on our website.
Groundbreaking Study Confirms Billions of People Worldwide Are Deficient in Essential Micronutrients
September 6, 2024UK Drug Regulator Warns Men on Common Prescription Drug Put Unborn Babies at Risk
September 13, 2024Vitamin B1 Linked to Reduced Fatigue in Some Inflammatory Bowel Disease Patients
News
Fatigue is a common and often debilitating companion for people with inflammatory bowel conditions. A new Danish study provides insight into why vitamin B1 helps some patients regain their energy.
[Source: medicalxpress.com]
[Image source: Adobe Stock]
Comment
Published in the Gastro Hep Advances journal, this new study revealed that while vitamin B1 can help reduce fatigue in patients with inflammatory bowel disease (IBD), its effectiveness depends on specific gut bacteria. Researchers found that the presence of a beneficial bacterium, Faecalibacterium prausnitzii (FP), is linked to a positive response. This bacterium is often found in people with healthy guts, and its absence or low levels in those with chronic illness may explain why some patients do not benefit from the vitamin.
The study, involving 40 IBD patients with chronic fatigue, provided each participant with vitamin B1 and a placebo during two periods of four weeks with a break in between. While the researchers initially sought a “fatigue microbiome,” they discovered that the gut bacteria of fatigued patients largely resembled those without fatigue. However, the presence of FP in higher numbers was strongly associated with reduced fatigue after treatment with vitamin B1.
Based on these results, lead author Professor Christian Lodberg Hvas now recommends high-dose vitamin B1 for patients with unexplained fatigue, particularly since the treatment has no side effects and is affordable.
To learn about research using vitamin D to treat IBD, as well as how Dr. Rath’s Cellular Medicine approach to digestive health can help, see this article on our website.
Dr. Rath Health Foundation
Related posts
Efficacy of Mpox Vaccine Wanes Within a Year, Studies Reveal
Read more